Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of JX11502MA tablets in adults with acute schizophrenia
CTR20233105Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JX11502MA in schizophrenia, sponsored by Hengrui Therapeutics. Started Oct 2023; status: active.
02
Drugs
JX11502MA
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20233105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233105.